Ublituximab (Anti-CD20)
Ublituximab (Anti-CD20) is a chimeric recombinant IgG1 monoclonal antibody directed against human CD20 with potential antineoplastic activity. MW : 145.22 KD.
| Trivial name | LFB-R603; TG-1101; TGTX-1101 |
| Catalog Number | A2807 |
| CAS# | 1174014-05-1 |
| Size | 1mg |